Canaccord Genuity analysts downgraded Intra-Cellular Therapies (NASDAQ:ITCI) stock from Buy to Hold, adjusting the price target to $132 from the previous $119. The revision follows the recent ...
Former US adult star Emily Willis has reportedly been left 'permanently disabled' following treatment at a rehab centre. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback